研究課題
若手研究
Bullous Pemphigoid (BP), the most common autoimmune blistering skin disorder affecting the elderly population. Diabetes patients treated with dipeptidyl peptidase 4 inhibitor develop BP (DPP4i-BP) are increasing. We are studying the mechanism of the disease and its new potential treatment.